Comments on results of Scher et al. pertaining to nonprescription caffeine-containing combination analgesics

Cephalalgia

Volumn 30, Issue 9, 2010, Pages 1145-1146

  Delzell, Elizabeth ^a   Haag, Gunther ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Michael Balint Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BUTALBITAL; CAFFEINE; IBUPROFEN; NON PRESCRIPTION DRUG; OPIATE; PARACETAMOL;

CHRONIC DAILY HEADACHE; COMORBIDITY; DISEASE COURSE; DRUG USE; HEADACHE; HUMAN; LETTER; MIGRAINE; OBESITY; PAIN; PRIMARY HEADACHE; RISK FACTOR; SLEEP DISORDER; SOCIAL STATUS; TRANSFORMED MIGRAINE;

ANALGESICS; CAFFEINE; DRUG COMBINATIONS; HEADACHE DISORDERS; HEADACHE DISORDERS, SECONDARY; HUMANS; NONPRESCRIPTION DRUGS; PHOSPHODIESTERASE INHIBITORS;

EID: 78449303896     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410361540     Document Type: Letter

References (6)

1. Scher AI, Lipton RB, Stewart WF, Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study. Cephalalgia 2009 ; 30 (accessed December 2009 ).
2. Scher AI, Midgette LA, Lipton RB Risk factors for headache chronification. Headache 2008 ; 48: 16-25.
3. Midgette LA, Scher AI The epidemiology of chronic daily headache. Curr Pain Headache Rep 2009 ; 13: 59-63.
4. Bigal ME, Lipton RB Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 2009 ; 13: 301-307.
5. Bigal ME, Serrano D., Buse D., Scher A., Stewart WF, Lipton RB Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008 ; 48: 1157-1168.
6. Scher AI, Stewart WF, Lipton RB Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology 2004 ; 63: 2022-2027.